Both Semaglutide and phentermine share the common mechanism of helping to reduce appetite to facilitate weight loss
Mimic natural GLP-1 hormone better glucose control Slow gastric emptying increased satiety Promote significant weight loss Reduce cardiovascular risks in many patients Key insights: Once-weekly injections improve patient compliance Oral options like Rybelsus are expanding accessibility Dual agonists (like tirzepatide) are pushing outcomes even further But its not just about benefits: Common adverse effects include nausea, vomiting, and GI discomforthighlighting the importance of dose titration and patient monitoring
NIH Squitti R, Siotto M, Polimanti R
Theyre becoming essential building blocks in modern food formulation
Diabetic mice developed more severe infections, experienced greater weight loss and higher viral loads, and showed increased activity of a fibrosis-related gene not observed in non-diabetic mice
If you use compounded medication, our home storage guide for compounded semaglutide or tirzepatide explains how to avoid freezer-related problems